OncoMed Pharmaceuticals' Series B - III Round

OncoMed Pharmaceuticals raised a round of funding on December 10, 2008. Investors include Delphi Ventures.

OncoMed Pharmaceuticals is a clinical-stage company focused on discovering and developing therapeutics targeting cancer stem cells, or CSCs, which are the subpopulation of cells in a tumor responsible…

Articles about OncoMed Pharmaceuticals' Series B - III Round: